Last reviewed · How we verify
NCT06202209
The Impact of Autonomic Function on Atrial Fibrillation Recurrence After Pulmonary Vein Ablation
trial testing Circumferential Pulmonary Vein Isolation in Atrial Fibrillation Recurrent in 100 participants. Status unknown.
30 June 2024
Quick facts
| Lead sponsor | China National Center for Cardiovascular Diseases |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 13 September 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Circumferential Pulmonary Vein Isolation
Conditions studied
- Atrial Fibrillation Recurrent — all drugs for Atrial Fibrillation Recurrent →
Sponsor
China National Center for Cardiovascular Diseases — full company profile →
Who can join
Adults 18 to 75, any sex, with Atrial Fibrillation Recurrent. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective and observational study. The investigator speculated that the use of DC in patients with paroxysmal AF can serve as a predictor for early and late AF recurrence following CPVI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06202209
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation Recurrent
Currently open trials in the same condition.
- NCT06111443 — Effect of Dapagliflozin on the Recurrence of Atrial Tachyarrhythmia in Patients Undergoing Catheter Ablation of Atrial F · Phase 2, PHASE3 · active not recruiting
- NCT06253000 — Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium · NA · recruiting
- NCT05266144 — Atrial Fibrillation Patients Treated With Catheter Ablation · recruiting
Other China National Center for Cardiovascular Diseases trials
Trials by the same sponsor.
- NCT07514988 — Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment · NA · not yet recruiting
- NCT07476456 — Skeletal Muscle Multi-omics Analysis and Risk Tailoring in Sudden Cardiac Death · not yet recruiting
- NCT07302659 — Aortic No-Touch vs Partial Aortic Clamping in Off-Pump CABG · NA · recruiting
- NCT07482683 — Predicting Post-Cardiac Surgery Acute Kidney Disease: A Machine Learning Approach · not yet recruiting
- NCT06787430 — Effects of Nicorandil on Microvascular Dysfunction in Patients With STEMI Undergoing Primary PCI · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06202209 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China National Center for Cardiovascular Diseases
- Last refreshed: 11 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06202209.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing